Solara Active Pharma Sciences Ltd

Notice Of The Ninth Annual General Meeting

Solara Active Pharma Sciences Limited has informed the exchange about the dispatch of Notice of Ninth Annual General Meeting (AGM) of the Company scheduled to be held on Friday, September 18, 2026

AGM/EGM / AGM View filing →

Reg. 34 (1) Annual Report.

Annual Report for the financial year ended March 31, 2026

Others / Reg. 34 (1) Annual Report View filing →

Business Responsibility and Sustainability Reporting (BRSR)

Business Responsibility and Sustainability Reporting for the financial year 2025-26.

Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →

Newspaper Publication

Solara Active Pharma Sciences Limited has informed the stock exchange regarding the Newspaper publication with respect to the Ninth Annual General Meeting.

Company Update / Newspaper Publication View filing →

Conversion Of Partly Paid-Up Rights Equity Shares Into Fully Paid-Up Equity Shares In Relation To The Rights Issue By The Company, Upon Receipt Of The Call Monies, As Applicable

Conversion of Partly paid-up Rights Equity Shares into fully paid-up Equity shares in relation to the rights issue by the Company, upon receipt of Call Monies, as applicable.

Company Update / General View filing →

Allotment of ESOP / ESPS

Solara Active Pharma Sciences Limited has informed the Exchange regarding allotment of 2250 equity shares pursuant to exercise of ESOP options

Company Update / Allotment of ESOP / ESPS View filing →

Update With Respect To Our Intimation Dated July 23, 2026, Regarding Appointment Of CIO And SMP Of The Company.

Solara Active Pharma Sciences Limited has informed the exchange regarding the update with respect to our intimation dated July 23, 2026, regarding appointment of Chief Information Officer ....

Company Update / General View filing →

Submission Of Machine Readable Copy Of Financial Results For The Quarter Ended June 30, 2026

Solara Active Pharma Sciences Limited has informed the exchange regarding submission of Machine Readable copy of Financial results for the quarter ended June 30, 2026

Company Update / General View filing →

Newspaper Publication

Solara Active Pharma Sciences Limited has informed the exchange about the copy of the Newspaper publication providing extract of the unaudited Financial Results (Standalone and Consolidated) ....

Company Update / Newspaper Publication View filing →

Intimation About Appointment Of Chief Information Officer (CIO)

Solara Active Pharma Sciences Limited has informed the exchange regarding the appointment of Mr. Ajit Manocha as Chief Information Officer (CIO) and designated him as Senior Management ....

Company Update / General View filing →

Allotment of ESOP / ESPS

Solara Active Pharma Sciences Limited has informed the Exchange regarding allotment of 2250 Equity Shares pursuant to exercise of ESOP options.

Company Update / Allotment of ESOP / ESPS View filing →

Statement Of Deviation And Variation For Funds Raised Under Rights Issue For The Quarter Ended June 30, 2026.

Solara Active Pharma Sciences Limited has informed the exchange that there is no Deviation and Variation of funds raised through Rights Issue for the quarter ended June 30, 2026

Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation View filing →

Monitoring Agency Report

Monitoring Agency Report for the quarter ended June 30, 2026

Company Update / Monitoring Agency Report View filing →

Analyst / Investor Meet - Outcome

Solara Active Pharma Sciences Limited has informed the exchange about the Audio Recording of the Q1 FY 27 Earnings call held on July 23, 2026, at 16.00 IST

Company Update / Analyst / Investor Meet View filing →

Board Meeting Intimation for Intimation Regarding Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015 ('Listing Regulations')

Solara Active Pharma Sciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2026 ,inter alia, to consider and approve the unaudited ....

Board Meeting / Board Meeting View filing →

Analyst / Investor Meet - Intimation

Solara Active Pharma Sciences Limited has informed the Exchange about the Schedule of Investors/Analysts call to be held on Thursday, July 23, 2026 at 4.00 PM IST to discuss the Company's ....

Company Update / Analyst / Investor Meet View filing →

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

The Company has informed the exchange about the Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30, 2026

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

Newspaper Publication

Copy of newspaper publication with respect to Final Reminder cum Forfeiture Notice for payment of Call money to partly paid equity shareholders

Company Update / Newspaper Publication View filing →

Approval Of The Reminder - Cum - Forfeiture Notice

Solara Active Pharma Sciences Limited has informed the exchange about the approval of the Reminder - cum- Forfeiture Notice, by the Rights Issue Committee members, to be issued to the partly ....

Company Update / General View filing →

Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 - Transfer Of Equity Shares Of The Company To The IEPF

Dispatch of notices regarding the transfer of equity shares to the IEPF in respect of the unclaimed and unpaid dividend for the financial year 2018-19

Company Update / General View filing →

Newspaper Publication

Copy of newspaper advertisement regarding dispatch of notices to shareholders for the transfer of equity shares to the IEPF in respect of the unclaimed and unpaid dividend for the financial ....

Company Update / Newspaper Publication View filing →

Closure of Trading Window

Intimation regarding closure of Trading Window for the quarter ended June 30 2026

Insider Trading / SAST / Closure of Trading Window View filing →

Allotment of ESOP / ESPS

Allotment of 2,250 Equity shares pursuant to exercise of Options under Solara Employee Stock Option Plan 2018

Company Update / Allotment of ESOP / ESPS View filing →

Allotment of ESOP / ESPS

Allotment of 70,000 Equity Shares pursuant to exercise of Options under Solara Employee Stock Option Plan 2024

Company Update / Allotment of ESOP / ESPS View filing →

Clarification sought from Solara Active Pharma Sciences Ltd

The Exchange has sought clarification from Solara Active Pharma Sciences Ltd on June 10, 2026, with reference to Movement in Volume. The reply is awaited.

Company Update / Clarification

Clarification On Volume Movement

Clarification in relation to the Email received from BSE on June 10, 2026 on Volume movement.

Company Update / General View filing →

Intimation - Special Window For Transfer And Dematerialisation Of Shares

Solara Active Pharma Sciences Limited has informed the exchange regarding the Special Window for Transfer and Dematerialisation of shares

Company Update / General View filing →